Common TitleINROADS
Official Title A Multicenter, Single Arm, Open-Label Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Phase Phase II
ClinicalTrials.gov NCT01199939
Categories Resistance/Virological FailureTreatment-NaiveTreatment-ExperiencedDual Therapy
Funding
IndustryJanssen
References
- Ruane PJ, Brinson C, Ramgopal M, et al. The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects. HIV Med. 2015;16:288-96.